These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1963759

  • 1. [An effective case of M-VAC therapy of advanced bladder cancer with extramammary Paget's disease].
    Miyamoto H, Iizawa H, Takahashi T, Miura T, Kinoshita Y, Kubota Y, Hosaka M.
    Hinyokika Kiyo; 1990 Dec; 36(12):1459-62. PubMed ID: 1963759
    [Abstract] [Full Text] [Related]

  • 2. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
    Hatano K, Kawashima A, Arai Y, Inoue H, Miyagawa Y, Takaha N, Nishimura K, Miyake O, Okuyama A.
    Hinyokika Kiyo; 2006 Oct; 52(10):801-3. PubMed ID: 17131872
    [Abstract] [Full Text] [Related]

  • 3. [A case of carcinomatous meningitis from transitional cell carcinoma of the urinary bladder].
    Hara Y, Kobayashi Y, Goto K, Tozuka K, Tokue A, Mochizuki M.
    Hinyokika Kiyo; 1994 Dec; 40(12):1113-7. PubMed ID: 7863865
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen.
    Sternberg CN, Yagoda A, Scher HI.
    Prog Clin Biol Res; 1988 Dec; 277():45-51. PubMed ID: 3054909
    [No Abstract] [Full Text] [Related]

  • 10. [Usefulness of magnetic resonance imaging for evaluation of therapeutic efficacy of bone metastases from bladder cancer: a case report].
    Urushibara M, Tsukamoto T, Horiuchi S, Negishi T.
    Hinyokika Kiyo; 1998 Jul; 44(7):501-3. PubMed ID: 9752607
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
    Keating JP, Zincke H, Hahn RG, Morgan WR.
    Prog Clin Biol Res; 1990 Jul; 353():119-27. PubMed ID: 2217409
    [No Abstract] [Full Text] [Related]

  • 13. [A case of lung metastases of bladder cancer in which thoracotomy was performed following M-VAC therapy].
    Masuda M, Hujii Y, Hirokawa M, Hasegawa H, Kido Y, Matsushita K.
    Hinyokika Kiyo; 1990 Oct; 36(10):1181-4. PubMed ID: 2264546
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.
    J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A case of primary transitional cell carcinoma of the prostate].
    Konya E, Nose K, Kiwamoto H, Kataoka K, Kajikawa H, Kurita T.
    Hinyokika Kiyo; 1999 Jun; 45(6):439-42. PubMed ID: 10442290
    [Abstract] [Full Text] [Related]

  • 17. [M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
    Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Nakatsu H, Kume T, Kodama M, Masu C.
    Hinyokika Kiyo; 1989 Aug; 35(8):1323-7. PubMed ID: 2683648
    [Abstract] [Full Text] [Related]

  • 18. [M-VAC chemotherapy for advanced urothelial cancer--side effects and their management].
    Noguchi S, Kubota Y, Shuin T, Masuda M, Misaki H, Yao M, Kondoh K, Sakuramoto T, Hosaka M.
    Hinyokika Kiyo; 1994 Aug; 40(8):677-82. PubMed ID: 7942364
    [Abstract] [Full Text] [Related]

  • 19. M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
    Sternberg CN, Yagoda A, Scher HI, Whitmore WF, Herr HW, Morse MJ, Sogani PC, Watson RC, Hollander PS, Fair WR.
    Prog Clin Biol Res; 1988 Aug; 260():481-5. PubMed ID: 3283768
    [No Abstract] [Full Text] [Related]

  • 20. [Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience].
    González Enguita C, Caro Cebrián C, Roncalés Badal A, Gil Sanz MJ, Martínez Bengoechea J, Rioja Sanz LA.
    Arch Esp Urol; 1990 Aug; 43 Suppl 2():197-204. PubMed ID: 2096779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.